Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Chih Yu

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|October 19, 2011
Thrombin induces inducible nitric oxide synthase expression via the MAPK, MSK1, and NF-κB signaling pathways in alveolar macrophagesChen-Chun Lin, Chung-Huang Shih, You-Lan Yang, et al.
Computer Methods and Programs in Biomedicine|January 9, 2020
Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniquesNai-Hua Lai, Wan-Chen Shen, Chun-Nin Lee, et al.
Plos One|March 31, 2015
The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosisChen Yuan Chiang, Kuan Jen Bai, Hsien Ho Lin, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 5, 2024
Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugsYi-Wen Huang, Ming-Chih Yu, Chih-Bin Lin, et al.
Scientific Reports|February 21, 2026
Xpert MTB/RIF assay as an initial diagnostic test in pulmonary tuberculosis: a multicenter prospective randomized pragmatic trialWei-Chang Huang, Yi-Wen Huang, Chih-Bin Lin, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 4, 2025
Active drug-safety monitoring and management in the treatment of rifampicin-resistant tuberculosis: a nationwide multicenter prospective studyChou-Jui Lin, Chih-Bin Lin, Shun-Tien Chien, et al.
Plos One|September 7, 2012
Improved consistency in dosing anti-tuberculosis drugs in Taipei, TaiwanChen-Yuan Chiang, Ming-Chih Yu, Hsiu-Chen Shih, et al.
International Journal of Molecular Sciences|February 4, 2016
Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired PneumoniaKok-Khun Yong, Jer-Hwa Chang, Ming-Hsien Chien, et al.
Indoor Air|December 29, 2019
Effect of ventilation improvement during a tuberculosis outbreak in underventilated university buildingsChun-Ru Du, Shun-Chih Wang, Ming-Chih Yu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 18, 2021
Tuberculosis treatment delay and nosocomial exposure remain important risks for patients undergoing regular hemodialysisMichael Lu, Yuh-Mou Sue, Han-Lin Hsu, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|October 19, 2011
Thrombin induces inducible nitric oxide synthase expression via the MAPK, MSK1, and NF-κB signaling pathways in alveolar macrophagesChen-Chun Lin, Chung-Huang Shih, You-Lan Yang, et al.
Computer Methods and Programs in Biomedicine|January 9, 2020
Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniquesNai-Hua Lai, Wan-Chen Shen, Chun-Nin Lee, et al.
Plos One|March 31, 2015
The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosisChen Yuan Chiang, Kuan Jen Bai, Hsien Ho Lin, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 5, 2024
Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugsYi-Wen Huang, Ming-Chih Yu, Chih-Bin Lin, et al.
Scientific Reports|February 21, 2026
Xpert MTB/RIF assay as an initial diagnostic test in pulmonary tuberculosis: a multicenter prospective randomized pragmatic trialWei-Chang Huang, Yi-Wen Huang, Chih-Bin Lin, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 4, 2025
Active drug-safety monitoring and management in the treatment of rifampicin-resistant tuberculosis: a nationwide multicenter prospective studyChou-Jui Lin, Chih-Bin Lin, Shun-Tien Chien, et al.
Plos One|September 7, 2012
Improved consistency in dosing anti-tuberculosis drugs in Taipei, TaiwanChen-Yuan Chiang, Ming-Chih Yu, Hsiu-Chen Shih, et al.
International Journal of Molecular Sciences|February 4, 2016
Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired PneumoniaKok-Khun Yong, Jer-Hwa Chang, Ming-Hsien Chien, et al.
Indoor Air|December 29, 2019
Effect of ventilation improvement during a tuberculosis outbreak in underventilated university buildingsChun-Ru Du, Shun-Chih Wang, Ming-Chih Yu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 18, 2021
Tuberculosis treatment delay and nosocomial exposure remain important risks for patients undergoing regular hemodialysisMichael Lu, Yuh-Mou Sue, Han-Lin Hsu, et al.
Pageof 7